SNE​/Scientific Specialist; Veterinary Biologicals and Emerging Therapies

Select how often (in days) to receive an alert:

Type of position: Seconded National Expert
Reference:EMA/SNE/11587
Job title:

SNE/Scientific Specialist (Veterinary Biologicals and Emerging Therapies)
Final date to receive applications:21 September 2026  CET

The European Medicines Agency is a decentralized body of the European Union with all its offices and Headquarters based in Amsterdam, the Netherlands.

Its core responsibility is the protection and promotion of public health through the evaluation and supervision of medicines.

We are looking for National experts on secondment. This means staff from other European public-sector bodies can work at the European Medicines Agency (EMA) for short periods of time through the national expert on secondment (SNE) programme. The aim of this programme is to enhance and develop the relationship between European public administrations.

SNEs serve a dual role: they bring their expertise to EMA and take back to their home administration the knowledge acquired during their period of secondment. SNEs remain in the service of their employer. Secondment is not equivalent to employment, nor does it lead to employment by EMA.Periods of secondment may lastbetween six months and two years. This is renewable once or more,up to a total of four years.

This announcement is governed by the Rules governing the secondment of national experts. For further information please visit our Careers portal.

The European Medicines Agency (EMA) is seeking a motivated Seconded National Expert (SNE) to join the Veterinary Biologicals and Emerging Therapies department (V-EI-BIO) at an exciting time of growth and transformation. As innovation in veterinary medicines accelerates, the number and complexity of marketing authorisation applications for biologicals, including immunologicals and novel therapies continue to increase. This role offers a unique opportunity to work at the forefront of regulatory science, contributing to the evaluation of novel technologies and helping shape the future regulatory framework established by the Biotech Act (BTA).

The successful candidate will play a key role in supporting the assessment and lifecycle management of novel veterinary therapies, including the development, implementation and follow-up of Risk Management Plans (RMPs), and other biological products.

The position will involve working closely with scientific committees, the Novel Therapies Working Party (NTWP), external experts and the European Commission to address complex scientific and regulatory challenges. It offers a unique opportunity to contribute to the classification and assessment of innovative veterinary products, support network-wide capacity building, and help establish processes and requirements that will underpin future regulatory activities in this rapidly evolving field.

This position is ideal for professionals with a strong scientific background and an interest in veterinary biologicals, innovation, stakeholder engagement and regulatory policy. By joining EMA, you will have the opportunity to make a meaningful contribution to the development and availability of innovative veterinary medicines, while helping to strengthen Europe's preparedness for the next generation of veterinary medicines.

• Support the scientific and procedural management of marketing authorisation applications for veterinary biologicals, including immunologicals, and novel veterinary therapies.
• Contribute to the assessment, implementation, and lifecycle monitoring of Risk Management Plans (RMPs) for novel therapies.
  
  Support the development and implementation of the regulatory framework for novel therapies under the Biotech Act, helping ensure organisational readiness for future legal requirements.
• Coordinate and contribute to the classification and scientific assessment of novel veterinary products, providing case-by-case scientific input and regulatory recommendations.
  
  Liaise with the Novel Therapies Working Party (NTWP), Operational Expert Groups (OEGs), external scientific experts, and other stakeholders to facilitate scientific discussions and regulatory decision-making.
• Contribute to interactions with the European Commission and the European medicines regulatory network on matters related to veterinary medicines and novel therapies.
• Contribute to the development and delivery of training and knowledge-sharing activities for the…